Evidence of impaired anterior segment fibrinolytic activity in chronic uveitis.
Purified homologous fibrinogen (2.4-9.4 mg) was injected intracamerally in cat eyes at approximate six months intervals for up to 30 months in order to assess, in vivo, the long-term impact of chronic uveitis on anterior segment fibrinolytic capability. Normal and acutely inflamed eyes responded with slow clotting, small clot formation and rapid lysis (2-3 days). Chronically inflamed eyes showed rapid clotting, larger clots and much slower lysis, with BCG-induced uveitis much slower than endotoxin-induced uveitis. Suppression of plasminogen activator levels within aqueous humor of chronically inflamed eyes was indicated, using modified fibrin plate methods. The normal balance between fibrinolysis and fibrinogenesis within tissues bounding the anterior chamber is apparently tilted in favor of the latter function when inflammation is prolonged.
D000818:Animals; D001500:BCG Vaccine / Q000009:adverse effects; D002415:Cats; D002908:Chronic Disease; D004731:Endotoxins / Q000009:adverse effects; D004926:Escherichia coli; D005123:Eye / Q000503:physiopathology*; D005340:Fibrinogen / Q000008:administration & dosage / Q000096:biosynthesis; D005342:Fibrinolysis; D066298:In Vitro Techniques; D007267:Injections; D014605:Uveitis / Q000139:chemically induced / Q000503:physiopathology*
D001500:BCG Vaccine; D004731:Endotoxins; D005340:Fibrinogen